Guide for Lung Cancer Gene Tests Published (CME/CE)
(MedPage Today) -- All patients with advanced lung adenocarcinoma should undergo testing for EGFR and ALK mutations to determine their eligibility for targeted therapies, according to jointly developed recommendations from three organizations.
Source: MedPage Today Pulmonary - Category: Respiratory Medicine Source Type: news
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Genetics | Lung Cancer | Respiratory Medicine